Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

about

The relentless crumbling of the renin-angiotensin system (RAS)-blockade halo.Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

P2860

Q37227223-3BB0347C-B1B1-440C-82DD-A8AC534FFFCC Q51743274-5EBFCE74-76A1-4BB9-BF7D-BB99B250C2F9

P2860

Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

Item

http://www.wikidata.org/entity/Q36948768

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Does renin angiotensin system ...... tment of people with diabetes?

@en

type

Item

label

Does renin angiotensin system ...... tment of people with diabetes?

@en

prefLabel

Does renin angiotensin system ...... tment of people with diabetes?

@en

P1476

Does renin angiotensin system ...... tment of people with diabetes?

@en

P2093

Barry R Davis

http://www.w3.org/2001/XMLSchema#string

Joshua I Barzilay

http://www.w3.org/2001/XMLSchema#string

Paul K Whelton

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Effect of valsartan on the incidence of diabetes and cardiovascular events

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Telmisartan, ramipril, or both in patients at high risk for vascular events.

P304

202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/ATM.2016.05.24

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27294098

http://www.w3.org/2001/XMLSchema#string

P932

4885898

http://www.w3.org/2001/XMLSchema#string

Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

about

P2860

P2860

Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932